FDAClass IISeptember 2, 2020

Losartan Potassium Tablets USP recall

Losartan Potassium Tablets USP, 50 mg, 90 count bottles, Rx only, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ by Hetero Labs…

Why was Losartan Potassium Tablets USP recalled?

Failed Tablet/Capsule Specification; complaint of bulging tablet

What should I do if I have this product?

Review the official FDA enforcement record for current instructions.

What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.

Is my product affected?

Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.

Which lot codes, UPCs or models are affected?

Batch # LOA19357A, exp. date 09/2021

Product
Losartan Potassium Tablets USP, 50 mg, 90 count bottles, Rx only, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ by Hetero Labs…
Recalling firm
Hetero Labs Limited (Unit V)
Quantity
43,512 bottles
Distribution
Product was distributed to major wholesalers/distributors throughout the United States.
Recall date
September 2, 2020
Classification
Class II
Status
Terminated
Agency
FDA (drug)
Open FDA enforcement record Latest recalls